---
created: '2026-02-13T14:55:30.580544Z'
description: Receptor tyrosine kinase that regulates cell growth, survival, and differentiation.
  A major target for cancer therapies (TKIs).
dg-home: false
dg-publish: true
gardenUsername: dev_admin
permalink: /garden/dev_admin/protein/egfr/
slug: egfr
tags:
- protein
- kinase
- cancer
- receptor
templateEngineOverride: njk
title: EGFR
type: protein
updated: '2026-02-13T14:55:30.580544Z'
---

{% raw %}
<h1>EGFR</h1>
<h2>Overview</h2>
<p><strong>Epidermal Growth Factor Receptor (EGFR)</strong>, also known as ErbB1 or HER1, is a transmembrane receptor tyrosine kinase. Upon binding by ligands such as EGF or TGF-alpha, it dimerizes and autophosphorylates, triggering downstream signaling pathways that promote cell growth and division.</p>
<p>Overexpression or mutational activation of EGFR drives many cancers, making it a critical therapeutic target. Inhibitors include small molecule <strong>Tyrosine Kinase Inhibitors (TKIs)</strong> like Gefitinib and Erlotinib, and <strong>Monoclonal Antibodies</strong> like Cetuximab.</p>
<h2>Signaling Pathways</h2>
<ol>
<li><strong>RAS-RAF-MEK-ERK</strong>: Cell proliferation.</li>
<li><strong>PI3K-AKT-mTOR</strong>: Cell survival and anti-apoptosis.</li>
<li><strong>JAK-STAT</strong>: Cell division and immune regulation.</li>
</ol>
<h2>Relationships</h2>
<h3>Participates in Pathway</h3>
<ul>
<li>→ <a href="/garden/dev_admin/pathway/egfr-signaling-pathway/" class="internal-link">EGFR Signaling Pathway</a> (pathway)</li>
<li>→ <a href="/garden/dev_admin/pathway/mapk-signaling-pathway/" class="internal-link">MAPK Signaling Pathway</a> (pathway)</li>
</ul>
<h3>Interacts With</h3>
<ul>
<li>← <a href="/garden/dev_admin/protein/egf/" class="internal-link">EGF</a> (protein) - <em>Ligand</em></li>
<li>← <a href="/garden/dev_admin/protein/tgf-alpha/" class="internal-link">TGF-alpha</a> (protein) - <em>Ligand</em></li>
<li>→ <a href="/garden/dev_admin/protein/kras/" class="internal-link">KRAS</a> (protein) - <em>Downstream effector</em></li>
<li>→ <a href="/garden/dev_admin/protein/akt1/" class="internal-link">AKT1</a> (protein) - <em>Downstream effector</em></li>
</ul>
<h3>Targeted By</h3>
<ul>
<li>⊣ <a href="/garden/dev_admin/drug/gefitinib/" class="internal-link">Gefitinib</a> (drug) - <em>TKI</em></li>
<li>⊣ <a href="/garden/dev_admin/drug/erlotinib/" class="internal-link">Erlotinib</a> (drug) - <em>TKI</em></li>
<li>⊣ <a href="/garden/dev_admin/drug/cetuximab/" class="internal-link">Cetuximab</a> (drug) - <em>Monoclonal Antibody</em></li>
</ul>
<h3>Related Conditions</h3>
<ul>
<li>→ <a href="/garden/dev_admin/condition/lung-cancer/" class="internal-link">Lung Cancer</a> (condition)</li>
<li>→ <a href="/garden/dev_admin/condition/colorectal-cancer/" class="internal-link">Colorectal Cancer</a> (condition)</li>
<li>→ <a href="/garden/dev_admin/condition/glioblastoma/" class="internal-link">Glioblastoma</a> (condition)</li>
</ul>
<h2>References</h2>
<ol>
<li><strong>UniProt</strong>: P00533 (EGFR_HUMAN)</li>
<li><strong>Review</strong>: Yarden, Y., &amp; Sliwkowski, M. X. (2001). &quot;Untangling the ErbB signalling network.&quot; <em>Nature Reviews Molecular Cell Biology</em>.</li>
</ol>

{% endraw %}